Panel Discussion | Who Should Get Embolic Protection Device During TAVR?

Monday, March 10, 2025

1:30 PM – 1:45 PM ET

Panel Moderator(s)

Samir R. Kapadia, MD, FSCAI

Chairman, Cardiovascular Medicine
Cleveland Clinic
Cleveland, Ohio, United States

Disclosure(s): No financial relationships to disclose
Alexandra J. Lansky, MD, FACC, FAHA, MSCAI, FESC

Professor of Medicine
Yale School of Medicine
New Haven, Connecticut, United States

Disclosure information not submitted.
Axel Linke, MD

Head of Cardiology
Technical University Dresden, Heart Center
Dresden, Sachsen, Germany

Disclosure information not submitted.

Panel Discussant(s)

Neel Butala, MD

Medical Director of Structural Heart Disease and Intervention
Rocky Mountain Regional VA Medical Center

Disclosure(s): Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)
David J. Cohen, MD, FSCAI

Director of Clinical and Outcomes Research
Cardiovascular Research Foundation
New York, New York, United States

Disclosure(s): Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)
Michael G. Dwyer, PhD

Associate Professor of Neurology and Biomedical Informatics
University at Buffalo
Buffalo, New York, United States

Disclosure(s): ArchCath, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Bristol Meyers Squibb: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Protembis GmbH: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)

Disclosure(s):

Tariq Enezate, MD: No financial relationships to disclose

Samir R. Kapadia, MD, FSCAI: No financial relationships to disclose

Neel Butala, MD: Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing); Catch Bio: Consultant (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); HiLabs: Consulting Fees (e.g., advisory boards) (Ongoing), Ownership Interest (stocks, stock options, patent or other intellectual property or other ownership interest excluding diversified mutual funds) (Ongoing); Shockwave Medical: Consulting Fees (e.g., advisory boards) (Ongoing)

David J. Cohen, MD, FSCAI: Abbott Labs: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Boston Scientific Corporation: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); CathWorks: Grant/Research Support (Ongoing); Corvia Medical, Inc.: Grant/Research Support (Ongoing); Edwards Lifesciences LLC: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Medtronic, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing); Philips: Grant/Research Support (Ongoing); Zoll Medical: Grant/Research Support (Ongoing)

Michael G. Dwyer, PhD: ArchCath, Inc.: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Bristol Meyers Squibb: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing); Genentech: Grant/Research Support (Ongoing); Protembis GmbH: Consulting Fees (e.g., advisory boards) (Ongoing), Grant/Research Support (Ongoing)